摘要
分析药品制造这一特殊行业,以采购、制造、销售三级供应链为模型,在“后疫情”时代面对全球性的供应链涨价,对药品制造供应链上下游各环节遇到的困难进行了研究,认为供应链上游涨价对药品制造供应链的影响较大,并提出了药品制造供应链各节点应对的策略。
In light of the global supply chain price rising in the post-pandemic era, the paper studied the difficulties of each of the upstream and downstream links of the drug manufacturing supply chain, and concluded that upstream price rising had prominent impact on the drug manufacturing supply chain and proposed countermeasures for each node of the drug manufacturing supply chain.
作者
罗细飞
陈静漪
罗建军
郭伟
LUO Xifei;CHEN Jingyi;LUO Jianjun;GUO Wei(Supply Chain Operation Center,Yunnan Baiyao Group Co.,LTD.,Kunming 650500;Shenzhen Pengcheng Technician College,Shenzhen 518000;School of Management,Wuhan Textile University,Wuhan 430073,China)
出处
《物流技术》
2022年第12期98-102,共5页
Logistics Technology
基金
湖北省普通高等学校人文社会科学重点研究基地-企业决策支持研究中心重点项目(DSS20200704)。
关键词
药品制造供应链
上游涨价
采购
制造
销售
drug manufacturing supply chain
upstream price rising
purchasing
manufacturing
sales